Blue Eye Disease Vaccines Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 31-Jan-2023
No. of pages: 71

PoRV causes a disease commonly referred to as "blue eye disease" because of the corneal opacity seen in some affected pigs

This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines. This report contains market size and forecasts of Blue Eye Disease Vaccines in global, including the following market information:

Global Blue Eye Disease Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Blue Eye Disease Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Blue Eye Disease Vaccines companies in 2022 (%)

The global Blue Eye Disease Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Blue Eye Disease Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blue Eye Disease Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blue Eye Disease Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Blue Eye Disease Vaccines Market Segment Percentages, by Type, 2022 (%)

- Live Vaccines

- Killed Vaccines

Global Blue Eye Disease Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Blue Eye Disease Vaccines Market Segment Percentages, by Application, 2022 (%)

- Piglets

- Adult Pigs

Global Blue Eye Disease Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Blue Eye Disease Vaccines Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blue Eye Disease Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Blue Eye Disease Vaccines revenues share in global market, 2022 (%)

Key companies Blue Eye Disease Vaccines sales in global market, 2018-2023 (Estimated), (K Units)

Key companies Blue Eye Disease Vaccines sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- CAHIC

- Merial

- MSD Animal Health

- Chopper Biology

- Ceva

- ChengDu Tecbond

- Veterinary

- Ringpu Biology

- Qilu Animal

- DHN

Outline of Major Chapters:

Chapter 1: Introduces the definition of Blue Eye Disease Vaccines, market overview.

Chapter 2: Global Blue Eye Disease Vaccines market size in revenue and volume.

Chapter 3: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Blue Eye Disease Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Blue Eye Disease Vaccines capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Blue Eye Disease Vaccines Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Blue Eye Disease Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blue Eye Disease Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blue Eye Disease Vaccines Overall Market Size
2.1 Global Blue Eye Disease Vaccines Market Size: 2022 VS 2029
2.2 Global Blue Eye Disease Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blue Eye Disease Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Blue Eye Disease Vaccines Players in Global Market
3.2 Top Global Blue Eye Disease Vaccines Companies Ranked by Revenue
3.3 Global Blue Eye Disease Vaccines Revenue by Companies
3.4 Global Blue Eye Disease Vaccines Sales by Companies
3.5 Global Blue Eye Disease Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blue Eye Disease Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blue Eye Disease Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blue Eye Disease Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Blue Eye Disease Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Blue Eye Disease Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blue Eye Disease Vaccines Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type - Global Blue Eye Disease Vaccines Revenue & Forecasts
4.2.1 By Type - Global Blue Eye Disease Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Blue Eye Disease Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Blue Eye Disease Vaccines Sales & Forecasts
4.3.1 By Type - Global Blue Eye Disease Vaccines Sales, 2018-2023
4.3.2 By Type - Global Blue Eye Disease Vaccines Sales, 2024-2029
4.3.3 By Type - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Blue Eye Disease Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blue Eye Disease Vaccines Market Size, 2022 & 2029
5.1.2 Piglets
5.1.3 Adult Pigs
5.2 By Application - Global Blue Eye Disease Vaccines Revenue & Forecasts
5.2.1 By Application - Global Blue Eye Disease Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Blue Eye Disease Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Blue Eye Disease Vaccines Sales & Forecasts
5.3.1 By Application - Global Blue Eye Disease Vaccines Sales, 2018-2023
5.3.2 By Application - Global Blue Eye Disease Vaccines Sales, 2024-2029
5.3.3 By Application - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Blue Eye Disease Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Blue Eye Disease Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Blue Eye Disease Vaccines Revenue & Forecasts
6.2.1 By Region - Global Blue Eye Disease Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Blue Eye Disease Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Blue Eye Disease Vaccines Sales & Forecasts
6.3.1 By Region - Global Blue Eye Disease Vaccines Sales, 2018-2023
6.3.2 By Region - Global Blue Eye Disease Vaccines Sales, 2024-2029
6.3.3 By Region - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Blue Eye Disease Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Blue Eye Disease Vaccines Sales, 2018-2029
6.4.3 US Blue Eye Disease Vaccines Market Size, 2018-2029
6.4.4 Canada Blue Eye Disease Vaccines Market Size, 2018-2029
6.4.5 Mexico Blue Eye Disease Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Blue Eye Disease Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Blue Eye Disease Vaccines Sales, 2018-2029
6.5.3 Germany Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.4 France Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.5 U.K. Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.6 Italy Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.7 Russia Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Blue Eye Disease Vaccines Market Size, 2018-2029
6.5.9 Benelux Blue Eye Disease Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Blue Eye Disease Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Blue Eye Disease Vaccines Sales, 2018-2029
6.6.3 China Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.4 Japan Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.5 South Korea Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Blue Eye Disease Vaccines Market Size, 2018-2029
6.6.7 India Blue Eye Disease Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Blue Eye Disease Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Blue Eye Disease Vaccines Sales, 2018-2029
6.7.3 Brazil Blue Eye Disease Vaccines Market Size, 2018-2029
6.7.4 Argentina Blue Eye Disease Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blue Eye Disease Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Blue Eye Disease Vaccines Sales, 2018-2029
6.8.3 Turkey Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.4 Israel Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Blue Eye Disease Vaccines Market Size, 2018-2029
6.8.6 UAE Blue Eye Disease Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAHIC
7.1.1 CAHIC Company Summary
7.1.2 CAHIC Business Overview
7.1.3 CAHIC Blue Eye Disease Vaccines Major Product Offerings
7.1.4 CAHIC Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 CAHIC Key News & Latest Developments
7.2 Merial
7.2.1 Merial Company Summary
7.2.2 Merial Business Overview
7.2.3 Merial Blue Eye Disease Vaccines Major Product Offerings
7.2.4 Merial Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merial Key News & Latest Developments
7.3 MSD Animal Health
7.3.1 MSD Animal Health Company Summary
7.3.2 MSD Animal Health Business Overview
7.3.3 MSD Animal Health Blue Eye Disease Vaccines Major Product Offerings
7.3.4 MSD Animal Health Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 MSD Animal Health Key News & Latest Developments
7.4 Chopper Biology
7.4.1 Chopper Biology Company Summary
7.4.2 Chopper Biology Business Overview
7.4.3 Chopper Biology Blue Eye Disease Vaccines Major Product Offerings
7.4.4 Chopper Biology Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Chopper Biology Key News & Latest Developments
7.5 Ceva
7.5.1 Ceva Company Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Blue Eye Disease Vaccines Major Product Offerings
7.5.4 Ceva Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Ceva Key News & Latest Developments
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Company Summary
7.6.2 ChengDu Tecbond Business Overview
7.6.3 ChengDu Tecbond Blue Eye Disease Vaccines Major Product Offerings
7.6.4 ChengDu Tecbond Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 ChengDu Tecbond Key News & Latest Developments
7.7 Veterinary
7.7.1 Veterinary Company Summary
7.7.2 Veterinary Business Overview
7.7.3 Veterinary Blue Eye Disease Vaccines Major Product Offerings
7.7.4 Veterinary Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Veterinary Key News & Latest Developments
7.8 Ringpu Biology
7.8.1 Ringpu Biology Company Summary
7.8.2 Ringpu Biology Business Overview
7.8.3 Ringpu Biology Blue Eye Disease Vaccines Major Product Offerings
7.8.4 Ringpu Biology Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Ringpu Biology Key News & Latest Developments
7.9 Qilu Animal
7.9.1 Qilu Animal Company Summary
7.9.2 Qilu Animal Business Overview
7.9.3 Qilu Animal Blue Eye Disease Vaccines Major Product Offerings
7.9.4 Qilu Animal Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Qilu Animal Key News & Latest Developments
7.10 DHN
7.10.1 DHN Company Summary
7.10.2 DHN Business Overview
7.10.3 DHN Blue Eye Disease Vaccines Major Product Offerings
7.10.4 DHN Blue Eye Disease Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 DHN Key News & Latest Developments
8 Global Blue Eye Disease Vaccines Production Capacity, Analysis
8.1 Global Blue Eye Disease Vaccines Production Capacity, 2018-2029
8.2 Blue Eye Disease Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Blue Eye Disease Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blue Eye Disease Vaccines Supply Chain Analysis
10.1 Blue Eye Disease Vaccines Industry Value Chain
10.2 Blue Eye Disease Vaccines Upstream Market
10.3 Blue Eye Disease Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blue Eye Disease Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Blue Eye Disease Vaccines in Global Market
Table 2. Top Blue Eye Disease Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Blue Eye Disease Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Blue Eye Disease Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Blue Eye Disease Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Blue Eye Disease Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Blue Eye Disease Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Blue Eye Disease Vaccines Product Type
Table 9. List of Global Tier 1 Blue Eye Disease Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blue Eye Disease Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Blue Eye Disease Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Blue Eye Disease Vaccines Sales (K Units), 2024-2029
Table 16. By Application - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Blue Eye Disease Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Blue Eye Disease Vaccines Sales (K Units), 2024-2029
Table 21. By Region - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Blue Eye Disease Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Blue Eye Disease Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Blue Eye Disease Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Blue Eye Disease Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Blue Eye Disease Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Blue Eye Disease Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Blue Eye Disease Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Blue Eye Disease Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Blue Eye Disease Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Blue Eye Disease Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Blue Eye Disease Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Blue Eye Disease Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Blue Eye Disease Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Blue Eye Disease Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Blue Eye Disease Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Blue Eye Disease Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Blue Eye Disease Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Blue Eye Disease Vaccines Sales, (K Units), 2024-2029
Table 46. CAHIC Company Summary
Table 47. CAHIC Blue Eye Disease Vaccines Product Offerings
Table 48. CAHIC Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. CAHIC Key News & Latest Developments
Table 50. Merial Company Summary
Table 51. Merial Blue Eye Disease Vaccines Product Offerings
Table 52. Merial Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merial Key News & Latest Developments
Table 54. MSD Animal Health Company Summary
Table 55. MSD Animal Health Blue Eye Disease Vaccines Product Offerings
Table 56. MSD Animal Health Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. MSD Animal Health Key News & Latest Developments
Table 58. Chopper Biology Company Summary
Table 59. Chopper Biology Blue Eye Disease Vaccines Product Offerings
Table 60. Chopper Biology Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Chopper Biology Key News & Latest Developments
Table 62. Ceva Company Summary
Table 63. Ceva Blue Eye Disease Vaccines Product Offerings
Table 64. Ceva Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Ceva Key News & Latest Developments
Table 66. ChengDu Tecbond Company Summary
Table 67. ChengDu Tecbond Blue Eye Disease Vaccines Product Offerings
Table 68. ChengDu Tecbond Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. ChengDu Tecbond Key News & Latest Developments
Table 70. Veterinary Company Summary
Table 71. Veterinary Blue Eye Disease Vaccines Product Offerings
Table 72. Veterinary Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Veterinary Key News & Latest Developments
Table 74. Ringpu Biology Company Summary
Table 75. Ringpu Biology Blue Eye Disease Vaccines Product Offerings
Table 76. Ringpu Biology Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Ringpu Biology Key News & Latest Developments
Table 78. Qilu Animal Company Summary
Table 79. Qilu Animal Blue Eye Disease Vaccines Product Offerings
Table 80. Qilu Animal Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Qilu Animal Key News & Latest Developments
Table 82. DHN Company Summary
Table 83. DHN Blue Eye Disease Vaccines Product Offerings
Table 84. DHN Blue Eye Disease Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. DHN Key News & Latest Developments
Table 86. Blue Eye Disease Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Blue Eye Disease Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Blue Eye Disease Vaccines Production by Region, 2018-2023 (K Units)
Table 89. Global Blue Eye Disease Vaccines Production by Region, 2024-2029 (K Units)
Table 90. Blue Eye Disease Vaccines Market Opportunities & Trends in Global Market
Table 91. Blue Eye Disease Vaccines Market Drivers in Global Market
Table 92. Blue Eye Disease Vaccines Market Restraints in Global Market
Table 93. Blue Eye Disease Vaccines Raw Materials
Table 94. Blue Eye Disease Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Blue Eye Disease Vaccines Downstream
Table 96. Blue Eye Disease Vaccines Downstream Clients in Global Market
Table 97. Blue Eye Disease Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blue Eye Disease Vaccines Segment by Type in 2022
Figure 2. Blue Eye Disease Vaccines Segment by Application in 2022
Figure 3. Global Blue Eye Disease Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blue Eye Disease Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blue Eye Disease Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Blue Eye Disease Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blue Eye Disease Vaccines Revenue in 2022
Figure 9. By Type - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Blue Eye Disease Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Blue Eye Disease Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Blue Eye Disease Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Blue Eye Disease Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 23. US Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 37. China Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Blue Eye Disease Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Blue Eye Disease Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Blue Eye Disease Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Blue Eye Disease Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Blue Eye Disease Vaccines by Region, 2022 VS 2029
Figure 54. Blue Eye Disease Vaccines Industry Value Chain
Figure 55. Marketing Channels
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs